Project Grant HT94252311020
Award Date
9/15/23
Completion Date
9/14/26
Dollars Obligated
$513K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $523,266 project grant to the University of California Irvine. The 3-year grant, awarded on Sep 15, 2023, will support intravital imaging research on melanoma tumors to improve understanding of the mechanisms of action and patient surveillance for checkpoint blockade immunotherapy. The project aims to leverage UC Irvine's research capabilities and specialized facilities in biomedical...
This Project Grant award of $519,854.00 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports intravital imaging research of melanoma tumors at the University of California Irvine. The goal is to discover mechanisms and improve patient surveillance after checkpoint blockade immunotherapy. The award, with a start date of September 15, 2023 and completion date of September 14, 2026, will fund research to transform healthcare for Service Members...
The University of California Irvine was awarded a $1,413,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on an epigenetic approach for alleviating enzalutamide resistance in prostate cancer. This 3-year research project, with a start date of June 1, 2024 and an expected completion date of May 31, 2027, aims to develop innovative treatments for prostate cancer patients who have become resistant to the...
The University of California Irvine received a $156,998 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the development of personalized therapeutic cancer vaccines to effectively mobilize antitumor T-cell immunity in non-small cell lung cancer from September 30, 2021 through September 29, 2023. As the sub-awardee, the State of California Controllers Office will...
The University of California, Irvine received a $155,511 Department of Defense Project Grant under the Basic Scientific Research (CFDA 12.431) program. The grant, awarded on January 6, 2025, will fund the development of a "MICROSCOPE FOR ENVIRONMENTAL EXTREMES" to advance fundamental knowledge and capabilities in areas critical to national security, such as materials science, aerospace engineering, and environmental monitoring. As a leading research institution, UC Irvine will leverage...
The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
The U.S. Department of Defense (DoD) awarded a $784,963 Project Grant to the University of California, Irvine (UC Irvine) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, funds research focused on "Interactions of Fine Particulate Matter Exposure and Gonadal Toxicity on Alzheimer's Disease Progression." UC Irvine, as a leading public research university with expertise across biomedical disciplines, will...
This $805,901 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding the University of California, San Francisco (UCSF) to investigate the molecular basis of cutaneous melanomas in non-Caucasian patients. The 3-year research project aims to advance scientific understanding of melanoma pathogenesis in diverse patient populations and explore new potential therapeutic approaches. As a leading academic medical center,...
The University of Virginia received a $921,351 project grant award on September 30, 2023 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to support research on "APPROACHES TO ENHANCE VACCINE-INDUCED TUMOR-INFILTRATING LYMPHOCYTES (VITILS) IN MELANOMA". This multi-year grant, scheduled for completion on September 29, 2026, aims to advance biomedical research that can transform healthcare for Service Members and the American public. The...
This $802,068 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of California, San Diego (UCSD) to investigate how sublethal apoptotic signaling promotes melanoma adaptation to immune attack. The research aims to transform health care for service members and the broader public through innovative and impactful biomedical studies. The grant provides funding for UCSD's...